Center for Scientific Review: Amended Notice of Meeting, 2115 [2015-00496]

Download as PDF rljohnson on DSK3VPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 10 / Thursday, January 15, 2015 / Notices Group; Respiratory Integrative Biology and Translational Research Study Section. Date: February 12–13, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact Person: Bradley Nuss, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4142, MSC7814, Bethesda, MD 20892, 301–451– 8754, nussb@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Pathogenic Eukaryotes Study Section. Date: February 12–13, 2015. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Best Western Tuscan Inn, 425 North Point Street, San Francisco, CA 94133. Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD 20892, 301 435– 2306, boundst@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Clinical Research and Field Studies of Infectious Diseases Study Section. Date: February 12–13, 2015. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Duke Street, 1456 Duke Street, Alexandria, VA 22314. Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301–435– 0903, saadisoh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Enabling Bioanalytical and Imaging Technologies. Date: February 13, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Arlington Capital View Hotel, Arlington, VA 22202. Contact Person: Maria DeBernardi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6158, MSC 7892, Bethesda, MD 20892, 301–435– 1355, debernardima@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 9, 2015. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2015–00495 Filed 1–14–15; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 14:13 Jan 14, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review: Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Sensorimotor Integration Study Section, February 06, 2015, 08:00 a.m. to February 06, 2015, 06:00 p.m., JW Marriott New Orleans, 614 Canal Street, New Orleans, LA, 70130 which was published in the Federal Register on January 08, 2015, 80 FR 1031. The meeting will be held at the Renaissance New Orleans Pere Marquette Hotel, 817 Common Street New Orleans, LA, 70112. The meeting date and time remain the same. The meeting is closed to the public. Dated: January 8, 2015. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–00496 Filed 1–14–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Council on Drug Abuse. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00024 Fmt 4703 Sfmt 9990 2115 Name of Committee: National Advisory Council on Drug Abuse. Date: February 3, 2015. Closed: 8:30 a.m. to 10:00 a.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852. Open: 10:15 a.m. to 4:00 p.m. Agenda: This portion of the meeting will be open to the public for announcements and reports of administrative, legislative, and program developments in the drug abuse field. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852. Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of Extramural Research, Office of the Director, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, NSC, Room 5274, MSC 9591, Rockville, MD 20892, 301–443–6487, sweiss@nida.nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.drugabuse.gov/NACDA/ NACDAHome.html, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: January 9, 2015. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–00487 Filed 1–14–15; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 80, Number 10 (Thursday, January 15, 2015)]
[Notices]
[Page 2115]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00496]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review: Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the 
Sensorimotor Integration Study Section, February 06, 2015, 08:00 a.m. 
to February 06, 2015, 06:00 p.m., JW Marriott New Orleans, 614 Canal 
Street, New Orleans, LA, 70130 which was published in the Federal 
Register on January 08, 2015, 80 FR 1031.
    The meeting will be held at the Renaissance New Orleans Pere 
Marquette Hotel, 817 Common Street New Orleans, LA, 70112. The meeting 
date and time remain the same. The meeting is closed to the public.

    Dated: January 8, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-00496 Filed 1-14-15; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.